Literature DB >> 12097819

Atorvastatin treatment prevents alterations in coronary smooth muscle nuclear Ca2+ signaling in diabetic dyslipidemia.

B R Wamhoff1, J L Dixon, M Sturek.   

Abstract

Atorvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, alters bulk myoplasmic Ca2+ regulation and inhibits phenotypic modulation and proliferation of vascular smooth muscle in culture. Nuclear Ca2+ (Ca(n)) signaling is tightly coupled to transcriptional events and cell growth. Therefore, we hypothesized that in vivo treatment with atorvastatin would attenuate alterations in mitogen-induced Ca(n) signaling associated with coronary atherosclerosis. Three groups of male Yucatan pigs were treated for 20 weeks: controls, alloxan-induced diabetics fed an atherogenic diet and diabetics fed an atherogenic diet plus atorvastatin (80 mg/day). Right coronary artery single-cell cytosolic Ca2+ (Ca(c)) and Ca(n) responses to the mitogen endothelin-1 (5 x 10(-8) M) were measured by laser confocal microscopy using the calcium indicator Fluo-4. We observed a 39% increase in Ca(c) and a 52% increase in Ca(n) responses to endothelin-1 in cells from diabetic dyslipidemic arteries compared to control. These alterations were prevented in animals treated with atorvastatin. We show that during proliferation, the nucleus of a smooth muscle cell becomes rounded and loses the characteristic multilobular shape, clefts and invaginations. Consistent with this, a redistribution of Ca2+ stores from a transnuclear morphology in controls to a more perinuclear morphology occurred in cells from diabetic dyslipidemic arteries and was prevented by atorvastatin. In addition, the peak Ca(n) responses to endothelin-1 were inversely correlated (r = 0.712) with the extent of the transnuclear distribution of Ca2+ stores and directly correlated (r = 0.874) with the extent of atherosclerosis, as assessed in vivo by intravascular ultrasound. These findings indicate that chronic treatment with atorvastatin directly decreases mitogen-induced Ca(n) mobilization, which we suggest is related to the spatial localization of Ca(n) stores. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12097819     DOI: 10.1159/000063686

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  8 in total

1.  A comparison of murine smooth muscle cells generated from embryonic versus induced pluripotent stem cells.

Authors:  Chang-Qing Xie; Huarong Huang; Sheng Wei; Long-Sheng Song; Jifeng Zhang; Raquel P Ritchie; Liangbiao Chen; Ming Zhang; Y Eugene Chen
Journal:  Stem Cells Dev       Date:  2009-06       Impact factor: 3.272

2.  Metabolic syndrome and coronary artery disease in Ossabaw compared with Yucatan swine.

Authors:  Zachary P Neeb; Jason M Edwards; Mouhamad Alloosh; Xin Long; Eric A Mokelke; Michael Sturek
Journal:  Comp Med       Date:  2010-08       Impact factor: 0.982

Review 3.  Decoding calcium signaling across the nucleus.

Authors:  André G Oliveira; Erika S Guimarães; Lídia M Andrade; Gustavo B Menezes; M Fatima Leite
Journal:  Physiology (Bethesda)       Date:  2014-09

Review 4.  Ca2+ regulatory mechanisms of exercise protection against coronary artery disease in metabolic syndrome and diabetes.

Authors:  Michael Sturek
Journal:  J Appl Physiol (1985)       Date:  2011-05-19

5.  Regulation of calcium signals in the nucleus by a nucleoplasmic reticulum.

Authors:  Wihelma Echevarría; M Fatima Leite; Mateus T Guerra; Warren R Zipfel; Michael H Nathanson
Journal:  Nat Cell Biol       Date:  2003-05       Impact factor: 28.824

6.  Diabetic dyslipidemia and exercise alter the plasma low-density lipoproteome in Yucatan pigs.

Authors:  Matthew R Richardson; Xianyin Lai; Joseph L Dixon; Michael Sturek; Frank A Witzmann
Journal:  Proteomics       Date:  2009-05       Impact factor: 3.984

7.  Exercise training decreases store-operated Ca2+entry associated with metabolic syndrome and coronary atherosclerosis.

Authors:  Jason M Edwards; Zachary P Neeb; Mouhamad A Alloosh; Xin Long; Ian N Bratz; Cassandra R Peller; James P Byrd; Sanjay Kumar; Alexander G Obukhov; Michael Sturek
Journal:  Cardiovasc Res       Date:  2009-09-10       Impact factor: 10.787

8.  Atorvastatin ameliorates the contractile dysfunction of the aorta induced by organ culture.

Authors:  Feng Zhou; Fang Rao; You-Qing Deng; Hui Yang; Su-Juan Kuang; Fei-Long Wu; Shu-Lin Wu; Yu-Mei Xue; Xiao-Mu Wu; Chun-Yu Deng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-09-04       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.